UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1463217
IRVING, TX
Position in BIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$235,822
+$35,103 QoQ
Shares Held
846
+38.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $79,548,568 across 13 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
527,850 | $41,293,705 | |
| 2 | ABT |
Abbott Laboratories
|
190,899 | $17,322,175 | |
| 3 | SYK |
Stryker Corp
|
24,033 | $7,566,549 | |
| 4 | STE |
STERIS plc
|
25,242 | $5,315,207 | |
| 5 | EW |
Edwards Lifesciences Corp
|
19,972 | $1,806,667 | |
| 6 | BSX |
Boston Scientific Corp
|
40,446 | $1,726,235 | |
| 7 | DXCM |
Dexcom Inc
|
19,104 | $1,286,654 | |
| 8 | PODD |
Insulet Corp
|
8,086 | $1,231,093 |
All Filings in BIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $235,822 | 846 | Shares | Defined | 2026-05-15 | |
| 2024-12-31 | $200,719 | 611 | Shares | Defined | 2025-02-13 | |
| 2024-03-31 | $212,364 | 614 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||